{
  "abstract": "The recent article by Castellana and Chiappetta presents data collected from the FDA Adverse Event Reporting System (FAERS) illustrating a long-standing but still insufficiently addressed issue: women experience adverse drug reactions at significantly higher rates than men. The reported 1.5-fold increased risk should, however, be interpreted with great caution due to the limitations of Adverse Event Reporting Systems, such as differential over-reporting and confounding factors. The 12% of missing gender data in this database also raises a notable concern.1",
  "authors": [
    {
      "affiliations": [
        "Department of Basic and Clinical Pharmacology and Toxicology, University of Rijeka Faculty of Medicine, Rijeka, Croatia"
      ],
      "name": "Andrej Belančić"
    },
    {
      "affiliations": [
        "Sestre Milosrdnice University Hospital Center, Catholic University of Croatia, Zagreb, Croatia"
      ],
      "name": "Ines Potočnjak"
    },
    {
      "affiliations": [
        "Université Rennes 2, Rennes, France",
        "Institut Universitaire de France (IUF), Paris, France"
      ],
      "name": "Florian Naudet"
    }
  ],
  "title": "Gender bias in biomedical research",
  "uid": "a5aeb3c4-a159-5dd1-8e04-53bc6685b385"
}